These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31501180)

  • 1. Trends in health care-associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys.
    Mitchell R; Taylor G; Rudnick W; Alexandre S; Bush K; Forrester L; Frenette C; Granfield B; Gravel-Tropper D; Happe J; John M; Lavallee C; McGeer A; Mertz D; Pelude L; Science M; Simor A; Smith S; Suh KN; Vayalumkal J; Wong A; Amaratunga K;
    CMAJ; 2019 Sep; 191(36):E981-E988. PubMed ID: 31501180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals.
    Gravel D; Taylor G; Ofner M; Johnston L; Loeb M; Roth VR; Stegenga J; Bryce E; ; Matlow A
    J Hosp Infect; 2007 Jul; 66(3):243-8. PubMed ID: 17574304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals.
    Simor AE; Williams V; McGeer A; Raboud J; Larios O; Weiss K; Hirji Z; Laing F; Moore C; Gravel D;
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):687-93. PubMed ID: 23739072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the prevalence of methicillin-resistant Staphylococcus aureus infection and indicators of nosocomial infection control measures: a population-based study in French hospitals.
    Grammatico-Guillon L; Thiolet JM; Bernillon P; Coignard B; Khoshnood B; Desenclos JC
    Infect Control Hosp Epidemiol; 2009 Sep; 30(9):861-9. PubMed ID: 19637957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.
    Simor AE; Pelude L; Golding G; Fernandes R; Bryce E; Frenette C; Gravel D; Katz K; McGeer A; Mulvey MR; Smith S; Weiss K;
    Infect Control Hosp Epidemiol; 2016 Apr; 37(4):390-7. PubMed ID: 26782274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of infection control program resources, activities, and antibiotic resistant organism rates in Canadian acute care hospitals in 1999 and 2005: pre- and post-severe acute respiratory syndrome.
    Zoutman DE; Ford BD
    Am J Infect Control; 2008 Dec; 36(10):711-7. PubMed ID: 18834747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of nosocomial isolates of Staphylococcus aureus with special reference to methicillin resistant S. aureus in a tertiary care hospital in Nepal.
    Shrestha B; Pokhrel B; Mohapatra T
    Nepal Med Coll J; 2009 Jun; 11(2):123-6. PubMed ID: 19968154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995-2007.
    Simor AE; Gilbert NL; Gravel D; Mulvey MR; Bryce E; Loeb M; Matlow A; McGeer A; Louie L; Campbell J;
    Infect Control Hosp Epidemiol; 2010 Apr; 31(4):348-56. PubMed ID: 20148693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Dare CR; Wares KD; Gould IM
    Lancet Infect Dis; 2015 Dec; 15(12):1438-49. PubMed ID: 26411518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed.
    Carlet J; Astagneau P; Brun-Buisson C; Coignard B; Salomon V; Tran B; Desenclos JC; Jarlier V; Schlemmer B; Parneix P; Regnier B; Fabry J;
    Infect Control Hosp Epidemiol; 2009 Aug; 30(8):737-45. PubMed ID: 19566444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of meticillin-resistant Staphylococcus aureus bloodstream infections in European hospitals: moving beyond policies.
    Borg MA; Hulscher M; Scicluna EA; Richards J; Azanowsky JM; Xuereb D; Huis A; Moro ML; Maltezou HC; Frank U
    J Hosp Infect; 2014 Aug; 87(4):203-11. PubMed ID: 24973016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the transmission dynamics of MRSA in the community and healthcare settings in a low-prevalence country.
    Di Ruscio F; Guzzetta G; Bjørnholt JV; Leegaard TM; Moen AEF; Merler S; Freiesleben de Blasio B
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14599-14605. PubMed ID: 31262808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National survey of methicillin-resistant Staphylococcus aureus in Belgian hospitals: detection methods, prevalence trends and infection control measures. The Groupement pour le Dépistage, l'Etude et la Prévention des Infections Hospitalières.
    Struelens MJ; Mertens R
    Eur J Clin Microbiol Infect Dis; 1994 Jan; 13(1):56-63. PubMed ID: 8168565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin-resistant Staphylococcus aureus (MRSA) in a tertiary surgical and trauma hospital in Benghazi, Libya.
    Buzaid N; Elzouki AN; Taher I; Ghenghesh KS
    J Infect Dev Ctries; 2011 Oct; 5(10):723-6. PubMed ID: 21997941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010.
    Jarvis WR; Jarvis AA; Chinn RY
    Am J Infect Control; 2012 Apr; 40(3):194-200. PubMed ID: 22440670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between "classical" risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strain.
    Vidal PM; Trindade PA; Garcia TO; Pacheco RL; Costa SF; Reinert C; Hiramatsu K; Mamizuka EM; Garcia CP; Levin AS
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):139-45. PubMed ID: 19146463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance.
    Simor AE; Ofner-Agostini M; Bryce E; Green K; McGeer A; Mulvey M; Paton S;
    CMAJ; 2001 Jul; 165(1):21-6. PubMed ID: 11468949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practices to prevent multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in Thailand: a national survey.
    Apisarnthanarak A; Khawcharoenporn T; Mundy LM
    Am J Infect Control; 2013 May; 41(5):416-21. PubMed ID: 23098775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare-associated infections and antimicrobial use in acute care hospitals: a point prevalence survey in Lombardy, Italy, in 2022.
    Antonelli A; Ales ME; Chiecca G; Dalla Valle Z; De Ponti E; Cereda D; Crottogini L; Renzi C; Signorelli C; Moro M
    BMC Infect Dis; 2024 Jun; 24(1):632. PubMed ID: 38918691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.
    Zarb P; Coignard B; Griskeviciene J; Muller A; Vankerckhoven V; Weist K; Goossens M; Vaerenberg S; Hopkins S; Catry B; Monnet D; Goossens H; Suetens C; ;
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.